Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:synthetic_progestogen |
| gptkbp:affiliatedWith |
19-nortestosterone derivatives
|
| gptkbp:ATCCode |
G03AC03
|
| gptkbp:CASNumber |
6533-00-2
|
| gptkbp:component |
gptkb:oral_contraceptive_pill
|
| gptkbp:developedBy |
1960s
|
| gptkbp:eliminationHalfLife |
8-24 hours
|
| gptkbp:excretion |
urine
|
| gptkbp:hasMolecularFormula |
C21H28O2
|
| gptkbp:isomerOf |
gptkb:levonorgestrel
gptkb:d-norgestrel l-norgestrel |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
1970
|
| gptkbp:mechanismOfAction |
inhibits ovulation
progestogenic activity |
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
gptkb:X_(US)
|
| gptkbp:PubChem_CID |
4524
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
headache breast tenderness menstrual changes |
| gptkbp:synonym |
Norlutin
dl-norgestrel rac-norgestrel |
| gptkbp:UNII |
8YB4FIW7B8
|
| gptkbp:usedFor |
contraception
|
| gptkbp:bfsParent |
gptkb:levonorgestrel
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
norgestrel
|